House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Dermatology

Diagnostic testing for treatment-refractory presumed atopic dermatitis

AAD · 2026 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

A focused summary of the AAD good practice statement for adults with presumed atopic dermatitis that remains refractory to treatment. The available recommendation supports reconsidering the diagnosis; the detailed testing scenarios in the full guideline are outside this summary.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Reconsider the diagnosis when treatment fails

  • In adults whose presumed atopic dermatitis remains unresponsive to management, consider further diagnostic workup. This is a good practice statement supporting reassessment, rather than a requirement to order a particular test in every patient. [2]

Limitations and use

  • This focused source bundle contains the exact single Good Practice Statement reproduced by Guideline Central and the AAD official scope statement. The full final guideline and its detailed testing scenarios were not acquired.
  • These excerpts support considering further workup or diagnostic reassessment in adults with presumed atopic dermatitis unresponsive to management. They do not establish which specific test to order, an ordering sequence, universal testing requirements, or a treatment algorithm.
  • This House summary is based on the linked focused or condensed recommendation sources; it does not represent the complete original publication.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Diagnostic testing for treatment-refractory presumed atopic dermatitis — reviewed source bundle part 1

    Selected recommendation material consulted

  2. 2
    Diagnostic testing for treatment-refractory presumed atopic dermatitis — reviewed source bundle part 2

    Selected recommendation material consulted

Clinical practice guideline

Publication details

Issuing organisation
AAD
First published
31 August 2026
Resource type
Clinical practice guideline · House clinical summary

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Reconsider the diagnosis when treatment fails
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House